...
机译:多中心的三氧化砷和indgar-Indigo Naturalis Indigo National indigo National indigo Naturalis公式中的急性突出细胞细胞白血病:SCCLG-APL临床研究的中期结果
Department of PediatricsXiangya Hospital Central South UniversityChangsha Hunan China;
Department of PediatricsSecond Xiangya Hospital Central South UniversityHunan China;
Department of PediatricsFirst Affiliated Hospital Sun Yat‐Sen UniversityGuangzhou China;
Department of HematologyHunan Childdren's HospitalChangsha Hunan China;
Department of PediatricsSun Yat‐Sen Memorial Hospital Sun Yat‐Sen UniversityGuangzhou China;
Department of PediatricsZhujiang Hospital Southern Medical UniversityGuangzhou China;
Department of Hematology and OncologyShenzhen Children's HospitalShenzhen China;
Department of Pediatric HematologyFujian Medical University Union HospitalFuzhou Fujian China;
Department of PediatricsThird Affiliated Hospital Sun Yat‐Sen UniversityGuangzhou China;
Department of PediatricsSun Yat‐Sen University Cancer CenterGuanzhou China;
Department of PediatricsHuizhou Municipal Central HospitalHuizhou Guangdong China;
Department of PediatricsFirst People's Hospital of HuizhouHuizhou Guangdong China;
Department of PediatricsNanfang Hospital Southern Medical UniversityGuangzhou China;
Department of PediatricsFirst Affiliated Hospital Sun Yat‐Sen UniversityGuangzhou China;
Clinical Trials Unit First Affiliated Hospital Sun Yat‐Sen UniversityGuangzhou China;
Department of PediatricsFirst Affiliated Hospital Sun Yat‐Sen UniversityGuangzhou China;
Department of PediatricsFirst Affiliated Hospital Sun Yat‐Sen UniversityGuangzhou China;
Department of PediatricsFirst Affiliated Hospital Sun Yat‐Sen UniversityGuangzhou China;
机译:多中心的三氧化砷和indgar-Indigo Naturalis Indigo National indigo National indigo Naturalis公式中的急性突出细胞细胞白血病:SCCLG-APL临床研究的中期结果
机译:用羊毛-Imgigo Naturalis公式(RIF)和全转反应醇(ATRA)治疗非高风险急性幼稚细胞白血病:用于随机对照试验的研究方案
机译:全反酸,雄黄-靛蓝自然配方配合化学疗法维持急性早幼粒细胞白血病的前瞻性疗效研究
机译:在四砷四硫化物治疗后,急性早幼细胞白血病(APL)患者的全血样品中的砷形式
机译:三氧化二砷和Realgar-Indigo naturalis配方在小儿急性早幼粒细胞白血病患者中的多中心随机试验:SCCLG-APL临床研究的中期结果
机译:用羊毛-Imgigo Naturalis公式(RIF)和全转反应醇(ATRA)治疗非高风险急性幼稚细胞白血病:用于随机对照试验的研究方案